search
Back to results

Identification of Spontaneous Delivery Markers (TrophY2)

Primary Purpose

Preterm Labor (24 GA - 32 GA)

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Cervicovaginal swab
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Preterm Labor (24 GA - 32 GA) focused on measuring Preterm labor, cervicovaginal secretions, markers of fetal membranes remodelling, Multiplex test

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

- Singleton pregnancy, monitored in Port Royal or secondarily transferred, between 24 and 32 GA. Hospitalization for preterm labor (cervix < 25 mm at transvaginal cervical ultrasound) or -Singleton pregnancy, monitered in Port Royal between 15-16 weeks of gestation, without complication.

or - Singleton pregnancy, monitered in Port Royal between 35-36 weeks of gestation, without complication.

or - Healthy woman, no pregnancy.

Exclusion Criteria:

  • Minor
  • Not affiliated to health insurance
  • Persons under guardianship or judicial protection
  • Infection with HIV, Hepatitis B Virus (HBV) or Hepatitis C Virus (HCV)
  • Diabetes or chronic inflammatory disease
  • Carrier of B streptococcus
  • Cervical strapping
  • Fetus with chromosomal abnormalities
  • Infections
  • Premature rupture of membrane

Sites / Locations

  • Maternité Port Royal-Cochin

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

Non pregnant women

Preterm Labor

Healthy pregnancy

Arm Description

Healthy pregnancy : women 15-16 weeks of gestation, at 35-36 weeks of gestation, and >37 weeks of gestation and planed cesarean prior labor

Pregnant women admitted for preterm labor

Healthy pregnancy : women 15-16 weeks of gestation, at 35-36 weeks of gestation, and >37 weeks of gestation and planed cesarean prior labor

Outcomes

Primary Outcome Measures

Delivery
Assessed among patients in preterm labor between 24 - 32 GA

Secondary Outcome Measures

Delivery before 34 GA
Assessed among patients in preterm labor between 24 - 32 GA
composite Prenatal maternal care
Assessed by : number of hospitalization, total duration of hospitalization for preterm labor, use of tocolytic treatment, administration of prenatal corticotherapy, time between the last injection of corticosteroids and birth
composite Neonatal outcome
Assessed by : birth weight, Apgar score at 5 minutes, arterial cord pH, transfer to neonatology unit or neonatal intensive care, death, In case of transfer neonatal unit or neonatal intensive care : duration of hospitalization, use of respiratory assistance
composite Obstetric outcome
Assessed by : pregnancy term, way to start labor (spontaneous, induction, caesarean before labor) duration of labor, maternal fever, antibiotics during labor, mode of delivery, indications of cesarean

Full Information

First Posted
August 7, 2014
Last Updated
June 15, 2018
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT02225717
Brief Title
Identification of Spontaneous Delivery Markers
Acronym
TrophY2
Official Title
Markers of Fetal Membranes Remodelling in Cervicovaginal Fluid and Delivery
Study Type
Interventional

2. Study Status

Record Verification Date
June 2018
Overall Recruitment Status
Completed
Study Start Date
December 14, 2014 (Actual)
Primary Completion Date
November 14, 2017 (Actual)
Study Completion Date
April 16, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators project aims to identify, in pregnant women, discriminating molecules to allow an early detection of women who will spontaneously deliver prematurely, suitable in routine clinical practice. Human parturition is tightly correlated with hormonal changes at the maternal-fetal interface during pregnancy, that may control cell interactions and fetal membranes (the water bag) remodelling. Precocious remodelling may lead to a premature onset of labor, associated or not with premature rupture of membrane whether the cause is infectious or not. In this regard, remodelled fetal membranes overlying the cervix may discharge signals that could be detectable in cervico-vaginal fluids and serve as biomarkers of the imminence of delivery. Such information on delivery timing may be of great importance for an adequate prediction that would change drastically the management of threatening preterm delivery.
Detailed Description
Prematurity is a major Public Health concern in developed countries, since it is the first cause of perinatal morbi-mortality and of cerebral palsy in early childhood. Premature birth rate has risen by 36 percent over the last 25 years to reach 7.2% in 2010 in France. Antenatal corticosteroids administration before 34 weeks and in utero transfer in high-qualified maternity wards are ones of the rare antenatal therapies recommended to improve neonatal complications of preterm delivery. Early identification of women with high risk of preterm birth should be helpful to implement those prophylactic measures. Moreover discriminating true preterm labor (PTL) vs. symptoms of PTL in women, who will finally deliver at term, would reduce unnecessary hospitalizations and prescriptions. During human gestation, fetal membranes (the "water bag") encompass the amnion, facing the amniotic cavity, and the chorion, lining the maternal decidua and comprising trophoblast cells. Membranes usually remain intact until their spontaneous rupture, close to the first stage of labor at term. Often seen as a simple inert shell, with a role of "airbag" for the developing fetus, the membranes provide yet a large surface of interaction between maternal and fetal tissues and function as a transient endocrine organ with immune properties. Specific remodelling of the membranes is observed at term prior to delivery. During this remodelling, drastic changes in extracellular matrix occur, with the secretion of specific molecules. The investigators hypothesize that premature fetal membranes remodelling occurs weeks prior to actual birth and may be able to be detected in women at risk for preterm birth, i.e. presenting signs of PTL. This study investigates if the detection of fetal membranes remodelling in cervico-vaginal fluids can accurately identify those women at greatest risk for preterm birth. A prospective cohort of pregnant women will before 32 weeks of gestation with symptoms of preterm labor be enrolled. As negative controls, healthy pregnant women at 12-15 or 35-36 weeks of gestation or non-pregnant women will be recruited. As positive controls, healthy pregnant woman at term (over 38 weeks of gestation) will be enrolled. The main outcome assessed is preterm delivery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preterm Labor (24 GA - 32 GA)
Keywords
Preterm labor, cervicovaginal secretions, markers of fetal membranes remodelling, Multiplex test

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
238 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Non pregnant women
Arm Type
Experimental
Arm Description
Healthy pregnancy : women 15-16 weeks of gestation, at 35-36 weeks of gestation, and >37 weeks of gestation and planed cesarean prior labor
Arm Title
Preterm Labor
Arm Type
Experimental
Arm Description
Pregnant women admitted for preterm labor
Arm Title
Healthy pregnancy
Arm Type
Experimental
Arm Description
Healthy pregnancy : women 15-16 weeks of gestation, at 35-36 weeks of gestation, and >37 weeks of gestation and planed cesarean prior labor
Intervention Type
Procedure
Intervention Name(s)
Cervicovaginal swab
Intervention Description
Sample of cervicovaginal secretions made by the surgical team using a sterile swab introduced directly into the posterior fornix of vagina for one minute during the insertion of the urinary catheter
Primary Outcome Measure Information:
Title
Delivery
Description
Assessed among patients in preterm labor between 24 - 32 GA
Time Frame
until Day 14
Secondary Outcome Measure Information:
Title
Delivery before 34 GA
Description
Assessed among patients in preterm labor between 24 - 32 GA
Time Frame
until Day 14
Title
composite Prenatal maternal care
Description
Assessed by : number of hospitalization, total duration of hospitalization for preterm labor, use of tocolytic treatment, administration of prenatal corticotherapy, time between the last injection of corticosteroids and birth
Time Frame
until Delivery
Title
composite Neonatal outcome
Description
Assessed by : birth weight, Apgar score at 5 minutes, arterial cord pH, transfer to neonatology unit or neonatal intensive care, death, In case of transfer neonatal unit or neonatal intensive care : duration of hospitalization, use of respiratory assistance
Time Frame
At Birth
Title
composite Obstetric outcome
Description
Assessed by : pregnancy term, way to start labor (spontaneous, induction, caesarean before labor) duration of labor, maternal fever, antibiotics during labor, mode of delivery, indications of cesarean
Time Frame
At Delivery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: - Singleton pregnancy, monitored in Port Royal or secondarily transferred, between 24 and 32 GA. Hospitalization for preterm labor (cervix < 25 mm at transvaginal cervical ultrasound) or -Singleton pregnancy, monitered in Port Royal between 15-16 weeks of gestation, without complication. or - Singleton pregnancy, monitered in Port Royal between 35-36 weeks of gestation, without complication. or - Healthy woman, no pregnancy. Exclusion Criteria: Minor Not affiliated to health insurance Persons under guardianship or judicial protection Infection with HIV, Hepatitis B Virus (HBV) or Hepatitis C Virus (HCV) Diabetes or chronic inflammatory disease Carrier of B streptococcus Cervical strapping Fetus with chromosomal abnormalities Infections Premature rupture of membrane
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Celine MEHATS, PhD
Organizational Affiliation
INSERM U1016 - Cochin Hospital Public Hospitals of Paris
Official's Role
Study Director
Facility Information:
Facility Name
Maternité Port Royal-Cochin
City
Paris
ZIP/Postal Code
75014
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
18328928
Citation
Larroque B, Ancel PY, Marret S, Marchand L, Andre M, Arnaud C, Pierrat V, Roze JC, Messer J, Thiriez G, Burguet A, Picaud JC, Breart G, Kaminski M; EPIPAGE Study group. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study. Lancet. 2008 Mar 8;371(9615):813-20. doi: 10.1016/S0140-6736(08)60380-3.
Results Reference
background
PubMed Identifier
10374127
Citation
McLaren J, Malak TM, Bell SC. Structural characteristics of term human fetal membranes prior to labour: identification of an area of altered morphology overlying the cervix. Hum Reprod. 1999 Jan;14(1):237-41. doi: 10.1093/humrep/14.1.237.
Results Reference
background
PubMed Identifier
8018607
Citation
Malak TM, Bell SC. Structural characteristics of term human fetal membranes: a novel zone of extreme morphological alteration within the rupture site. Br J Obstet Gynaecol. 1994 May;101(5):375-86. doi: 10.1111/j.1471-0528.1994.tb11908.x.
Results Reference
background

Learn more about this trial

Identification of Spontaneous Delivery Markers

We'll reach out to this number within 24 hrs